Nuveen Asset Management, LLC Neuronetics, Inc. Transaction History

Nuveen Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.09 - $3.71 $165,417 - $293,635	-79,147 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.84 - $4.52 $31 - $49	11 Added 0.01%	79,147 $264,000
Q4 2021 Feb 14, 2022	SELL	$3.87 - $6.59 $30,375 - $51,724	-7,849 Reduced 9.02%	79,136 $314,000
Q3 2021 Nov 12, 2021	SELL	$6.22 - $15.54 $5,996 - $14,980	-964 Reduced 1.1%	86,985 $560,000
Q2 2021 Aug 16, 2021	BUY	$10.15 - $17.25 $892,682 - $1.52 Million	87,949 New	87,949 $1.41 Million

Q2 2020 Aug 14, 2020	SELL	$1.41 - $2.61 $49,617 - $91,845	-35,190 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$1.28 - $4.5 $345 - $1,215	270 Added 0.77%	35,190 $66,000
Q4 2019 Feb 14, 2020	SELL	$4.03 - $9.22 $7,161 - $16,383	-1,777 Reduced 4.84%	34,920 $157,000
Q2 2019 Aug 15, 2019	BUY	$9.0 - $17.2 $330,273 - $631,188	36,697 New	36,697 $459,000

18.4M

200

3.6K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $47.3M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.